Reuben and Lee have further found that CD8+ T cells from the blood of patients with non-metastatic IBC had enhanced IFN-γ production responses upon T cell receptor (TCR)-stimulation, while IFN-γ production declined again toward levels of healthy donors in patients with metastatic IBC [28]. This evidence concerns the gene CD8A and inflammatory breast carcinoma.